Form S-4MEF - Registration adding securities to prior Form S-4 registration [Rule 462(b)]:
SEC Accession No. 0001104659-23-021675
Filing Date
2023-02-14
Accepted
2023-02-14 16:21:52
Documents
7
Effectiveness Date
2023-02-14

Document Format Files

Seq Description Document Type Size
1 S-4MEF tm236773d1_s4mef.htm S-4MEF 46644
2 EXHIBIT 5.1 tm236773d1_ex5-1.htm EX-5.1 10727
3 EXHIBIT 23.2 tm236773d1_ex23-2.htm EX-23.2 2006
4 EXHIBIT 23.3 tm236773d1_ex23-3.htm EX-23.3 1382
5 EXHIBIT 99.1 tm236773d1_ex99-1.htm EX-99.1 3144
6 EX-FILING FEES tm236773d1_ex-filingfees.htm EX-FILING FEES 29211
7 GRAPHIC tm236773d1_ex5-1img01.jpg GRAPHIC 2231
  Complete submission text file 0001104659-23-021675.txt   97489
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4MEF | Act: 33 | File No.: 333-269761 | Film No.: 23629815
SIC: 2834 Pharmaceutical Preparations